What is the clinical value of cancer stem cell markers in gliomas?
Odense, Denmark. In Int J Clin Exp Pathol, Dec 2012
Using the Pubmed database, twenty-seven CSC studies looking at membrane markers (CD133, podoplanin, CD15, and A2B5), filament markers (nestin), RNA-binding proteins (Musashi-1) and transcription factors (BMI1, SOX2, Id1 and Oct-4) qualified for this review.
Nestin and other putative cancer stem cell markers in pancreatic cancer.
Tokyo, Japan. In Med Mol Morphol, Jun 2012
Recently, several CSC-specific markers for pancreatic cancer have been reported, including CD133, CD24, CD44, CXCR4, EpCAM, ABCG2, c-Met, ALDH-1, and nestin, but their use is controversial.
Detection of cancer stem cell markers in sarcomas.
Brno, Czech Republic. In Klin Onkol, 2011
Special attention is paid to the detection of CD133, ABC transporters, nestin and aldehyde dehydrogenase that have been intensively studied both in tumour tissues and in sarcoma cell lines during the past few years.
Tissue microarray analysis of ezrin, KBA.62, CD166, nestin, and p-Akt in melanoma versus banal and atypical nevi, and nonmelanocytic lesions.
More papers using
Oklahoma City, United States. In Am J Dermatopathol, 2011
We sought to determine if ezrin, KBA.62, p-Akt, CD166, and nestin, may be helpful in distinguishing melanoma from nevi and atypical melanocytic lesions